Lytron SB 250mg/125mg Injection
Marketer
Lichem Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Lytron SB 250mg/125mg Injection
Combiflox, a 250mg/125mg injectable formulation, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, curbing infection spread. Administration requires strict medical oversight; adherence to the prescribed schedule is crucial. Treatment completion is vital, even with symptom improvement, as premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and dyspepsia are possible side effects; worsening symptoms necessitate immediate medical attention. Allergic reactions (e.g., rash, pruritus, edema, dyspnea) demand prompt medical intervention. Prior medication disclosure to your physician is essential, especially for pregnant or lactating individuals. Alcohol should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, drowsiness or dizziness warrants driving cessation. Adequate rest, balanced nutrition, and sufficient hydration promote optimal recovery. Your doctor may order tests to monitor the medication's effects.
Uses of Lytron SB 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Lytron SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Lytron SB 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Lytron SB 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Lytron SB 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, the components of Lytron SB 250mg/125mg Injection, act synergistically. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Lytron SB 250mg/125mg Injection can be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Lytron SB, containing 250mg/125mg, is typically deemed safe for pregnant individuals. Preclinical trials using animals have revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Lytron SB 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Lytron SB 250mg/125mg Injection can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Lytron SB 250mg/125mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Lytron SB 250mg/125mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Lytron SB 250mg/125mg Injection is unwarranted in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Lytron SB 250mg/125mg Injection :
Omitting a scheduled dose of Lytron SB 250mg/125mg Injection warrants immediate physician consultation.
Facts to Know About Lytron SB 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently